Search Results: cardiovascular health (344)

Breakthrough Trial Suggests GLP-1 Drugs Could Slow Alzheimer’s Progression Researchers have discovered that GLP-1 drugs, like liraglutide, may slow cognitive…

In the bustling urban centres and tranquil rural areas of the Philippines, a silent epidemic is taking hold: loneliness. 

Discover how telemedicine is improving access, reducing costs, and enhancing the quality of care for patients and doctors. The benefits…

As global populations continue to age, the pursuit of effective anti-ageing treatments has never been more urgent.  Recent findings from…

The Department of Trade and Industry (DTI) has announced that online sales of vape products will be suspended starting 20 July 2024. This action is a decisive move aimed at bolstering public health and ensuring compliance with regulatory standards. It is part of an effort to address concerns over the accessibility of these products to minors and to enforce controls on their distribution. 

Banned Substance Detected in V-SHOU Premium Coffee The Singapore Food Agency (SFA) has detected a banned substance, Sibutramine, in “V-SHOU…

In a significant development, Novartis has launched a cutting-edge therapy designed to lower bad cholesterol levels, providing hope for patients at high risk of cardiovascular issues. This innovative treatment has the potential to dramatically improve the lives of those dealing with high cholesterol, a key risk factor for heart disease and stroke.

A total of 376 Indonesian hajj pilgrims have died, with most of them caused by heat stroke. This alarming trend highlights the health and safety conditions of the pilgrims during the Hajj season.